Article
Envision Pharma Group
Market Access and the MSL Role
Summary
In this episode, Tom Caravela welcomes Ruchit Parikh to discuss the critical role of market access within the pharmaceutical industry. They explore the definition and significance of market access and how it intersects with MSL interactions. Ruchit identifies common knowledge gaps and provides advice on resources for MSLs in 2023. The conversation covers strategies for breaking into the MSL industry, addressing challenges, and setting professional goals for the New Year. The episode concludes with insights into career growth in medical affairs and a call to action for listeners.
Today’s guest is Ruchit Parikh, Associate Director, Medical Affairs Strategy and Training at CTI BioPharma and we discuss Market Access, what it is and how it fits into Medical Affairs
_This episode is sponsored by Larvol, Established in 2004, LARVOL combines the best of artificial and human intelligence to deliver expertly curated and personalized data solutions to medical affairs, competitive intelligence, commercial, and R&D teams within the pharmaceutical and biotech industry. For more details, please visit www.larvol.com
_Ruchit discusses….
๐ What is Market Access and why is it important to MSLs
๐ What do MSLs need to know about Market Access
๐ How does Market Access differ based on size of company
๐ What does the term “unicorn of skills” mean
๐ How can MSLs find success in 2023
Market Access, Pharmaceutical Industry, MSL Strategies, Medical Affairs, Career Growth
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois